<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-id journal-id-type="hwp">brain</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26715604</article-id>
<article-id pub-id-type="pmc">5841365</article-id>
<article-id pub-id-type="doi">10.1093/brain/awv371</article-id>
<article-id pub-id-type="publisher-id">awv371</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ebrahimi-Fakhari</surname>
<given-names>Darius</given-names>
</name>
<xref ref-type="aff" rid="awv371-AFF1">1</xref>
<xref ref-type="aff" rid="awv371-AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saffari</surname>
<given-names>Afshin</given-names>
</name>
<xref ref-type="aff" rid="awv371-AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wahlster</surname>
<given-names>Lara</given-names>
</name>
<xref ref-type="aff" rid="awv371-AFF2">2</xref>
<xref ref-type="aff" rid="awv371-AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Jenny</given-names>
</name>
<xref ref-type="aff" rid="awv371-AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Byrne</surname>
<given-names>Susan</given-names>
</name>
<xref ref-type="aff" rid="awv371-AFF4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>Georg F.</given-names>
</name>
<author-comment content-type="other">
<p>*<bold>These authors contributed equally to this work.</bold></p>
</author-comment>
<xref ref-type="aff" rid="awv371-AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jungbluth</surname>
<given-names>Heinz</given-names>
</name>
<author-comment content-type="other">
<p>*<bold>These authors contributed equally to this work.</bold></p>
</author-comment>
<xref ref-type="aff" rid="awv371-AFF4">4</xref>
<xref ref-type="aff" rid="awv371-AFF5">5</xref>
<xref ref-type="aff" rid="awv371-AFF6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<author-comment content-type="other">
<p>*<bold>These authors contributed equally to this work.</bold></p>
</author-comment>
<xref ref-type="aff" rid="awv371-AFF1">1</xref>
</contrib>
</contrib-group>
<aff id="awv371-AFF1">
<label><sup>1</sup></label>1 The F.M. Kirby Neurobiology Centre, Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA</aff>
<aff id="awv371-AFF2">
<label><sup>2</sup></label>2 Division of Paediatric Neurology and Inherited Metabolic Diseases, Department of Paediatrics, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany</aff>
<aff id="awv371-AFF3">
<label><sup>3</sup></label>3 Department of Haematology and Oncology, Stem Cell Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA</aff>
<aff id="awv371-AFF4">
<label><sup>4</sup></label>4 Department of Paediatric Neurology, Evelina’s Children Hospital, Guy’s and St. Thomas’ Hospital NHS Foundation Trust, London, UK</aff>
<aff id="awv371-AFF5">
<label><sup>5</sup></label>5 Randall Division for Cell and Molecular Biophysics, Muscle Signalling Section, King’s College London, London, UK</aff>
<aff id="awv371-AFF6">
<label><sup>6</sup></label>6 Department of Basic and Clinical Neuroscience, IoPPN, King’s College London, London, UK</aff>
<author-notes>
<corresp><bold>Correspondence to</bold>: Dr Darius Ebrahimi-Fakhari, The F.M. Kirby Neurobiology Centre, Department of Neurology, Boston Children’s Hospital, Harvard Medical School, 3 Blackfan Circle, CLSB 14060, MA 02115, USA E-mail: <email>darius.ebrahimi-fakhari@childrens.harvard.edu</email></corresp>
<fn id="awv371-FN1">
<p>*<bold>These authors contributed equally to this work.</bold></p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date iso-8601-date="2015-12-26" pub-type="epub">
<day>26</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>139</volume>
<issue>2</issue>
<fpage>317</fpage>
<lpage>337</lpage>
<history>
<date date-type="received">
<day>5</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="awv371.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>Mutations in autophagy genes cause childhood-onset multisystem diseases with predominant nervous system involvement and provide a ‘genetic window’ into autophagy's role in neurobiology and disease. In this review, Ebrahimi-Fakhari <italic>et al</italic>. examine the clinical and molecular spectrum of ‘congenital disorders of autophagy’, a novel class of inborn errors of metabolism.</p>
</abstract>
<abstract abstract-type="graphical">
<p>
<fig id="fig1g" orientation="portrait" position="float"><caption><p>Mutations in autophagy genes cause childhood-onset multisystem diseases with predominant nervous system involvement and provide a ‘genetic window’ into autophagy's role in neurobiology and disease. In this review, Ebrahimi-Fakhari <italic>et al</italic>. examine the clinical and molecular spectrum of ‘congenital disorders of autophagy’, a novel class of inborn errors of metabolism.</p></caption><graphic xlink:href="awv371fig1g"></graphic></fig>
</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>Single gene disorders of the autophagy pathway are an emerging, novel and diverse group of multisystem diseases in children. Clinically, these disorders prominently affect the central nervous system at various stages of development, leading to brain malformations, developmental delay, intellectual disability, epilepsy, movement disorders, and neurodegeneration, among others. Frequent early and severe involvement of the central nervous system puts the paediatric neurologist, neurogeneticist, and neurometabolic specialist at the forefront of recognizing and treating these rare conditions. On a molecular level, mutations in key autophagy genes map to different stages of this highly conserved pathway and thus lead to impairment in isolation membrane (or phagophore) and autophagosome formation, maturation, or autophagosome-lysosome fusion. Here we discuss ‘congenital disorders of autophagy’ as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: <italic>EPG5</italic>-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in <italic>WDR45</italic>, <italic>SNX14</italic>-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by <italic>SPG11</italic>, <italic>ZFYVE26</italic> and <italic>TECPR2</italic> mutations, respectively. We also highlight associations between defective autophagy and other inborn errors of metabolism such as lysosomal storage diseases and neurodevelopmental diseases associated with the mTOR pathway, which may be included in the wider spectrum of autophagy-related diseases from a pathobiological point of view. By exploring these emerging themes in disease pathogenesis and underlying pathophysiological mechanisms, we discuss how congenital disorders of autophagy inform our understanding of the importance of this fascinating cellular pathway for central nervous system biology and disease. Finally, we review the concept of modulating autophagy as a therapeutic target and argue that congenital disorders of autophagy provide a unique genetic perspective on the possibilities and challenges of pathway-specific drug development.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>autophagy</kwd>
<kwd>inborn errors of metabolism</kwd>
<kwd>mammalian target of rapamycin (mTOR)</kwd>
<kwd>neurodevelopment</kwd>
<kwd>neurodegeneration</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Child Health and Human Development</named-content>
<named-content content-type="funder-identifier">10.13039/100000071</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of General Medical Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100000057</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Mental Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000025</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Neurological Disorders and Stroke</named-content>
<named-content content-type="funder-identifier">10.13039/100000065</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Center for Advancing Translational Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100006108</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="21"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>